2021
DOI: 10.1007/s10557-021-07274-z
|View full text |Cite|
|
Sign up to set email alerts
|

RETRACTED ARTICLE: Differential Expression of LOXL1-AS1 in Coronary Heart Disease and its Regulatory Mechanism in ox-LDL-Induced Human Coronary Artery Endothelial Cell Pyroptosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(4 citation statements)
references
References 27 publications
0
4
0
Order By: Relevance
“…Silencing LOXL1-AS1 could promote HCAEC viability and reduce pyroptosis. 9) The above suggests that LOXL1-AS1 is closely associated with cardiovascular disease and that it may serve as a clinically significant predictor. However, its biological effects and regulatory mechanisms have not yet been explained in MIRI.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Silencing LOXL1-AS1 could promote HCAEC viability and reduce pyroptosis. 9) The above suggests that LOXL1-AS1 is closely associated with cardiovascular disease and that it may serve as a clinically significant predictor. However, its biological effects and regulatory mechanisms have not yet been explained in MIRI.…”
Section: Discussionmentioning
confidence: 99%
“… 21) Furthermore, LOXL1-AS1 enhanced ox-LDL-induced pyroptosis in human coronary endothelial cells by binding miR-16-5p. 9) According to the literature, in coronary heart disease, LOXL1-AS1 was noted to be significantly upregulated in the serum of patients with coronary heart disease and atherosclerosis. Silencing LOXL1-AS1 could promote HCAEC viability and reduce pyroptosis.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Studies have shown that serum in ammatory marker C-reactive protein (CRP) can predict the instability of coronary atherosclerotic plaque and is proportional to the incidence and severity of cardiovascular disease [23]. In addition, oxidized low-density lipoprotein (ox-LDL) degrades the brous cap of coronary atherosclerosis and increases plaque instability, and studies have shown that elevated levels of cholesterol and ox-LDL are the main causes of atherosclerosis [24]. To further verify the above views, we also focused on measuring CRP, ox-LDL, cholesterol and other indicators of CAD patients.…”
Section: Discussionmentioning
confidence: 99%